Reducing the Risks of HIV Research

When the annual meeting of the American Association for the Advancement of Science opens in Boston later this week, eight of its scores of sessions will deal with AIDS. That is far more attention than the meeting allocates to any other single topic. Even superconductivity, the glamour kid of science, gets only two. Despite all those days of discussion, judging by the condensed program available in advance of the meeting, the organizers have ignored a critical aspect of AIDS research: the safet

Written byTabitha Powledge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Despite all those days of discussion, judging by the condensed program available in advance of the meeting, the organizers have ignored a critical aspect of AIDS research: the safety of the researchers who are trying to make it go away. As we reported in our last issue (THE SCIENTIST, .January 25, 1987 p. 1), it is not clear that current lab safety procedures offer enough protection against HIV infection, even then they are carefully observed. A two-year study of 265 lab workers, published in Science on New Year's Day, disclosed that one of them had become infected with HIV even though he or she-the worker remains anonymous-had no known risk factors and appears to have violated no safety procedures.

Now of course it may turn out that the infected really did do something, either inside or outside the lab, that led to infection by one of the obvious routes. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery